EV/EBITDA
-4.39
+0.30+6.40%
4 min ago
Summary
- As of March 10, 2025, DNLI EV/EBITDA is -4.39, with a rise of +0.30 (+6.40%) during the most recent trading day.
- Over the past year, DNLI EV/EBITDA has increased by +12.11 (+73.39%).
- DNLI EV/EBITDA is now -102.34% below its all-time high of 187.57.
Performance
DNLI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
DNLI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +6.4% | -6.5% | -6.2% |
| 1 m1 month | +25.0% | -25.1% | -24.5% |
| 3 m3 months | +37.5% | -38.0% | -35.7% |
| 6 m6 months | +43.2% | -42.5% | -40.4% |
| ytdytd | +23.1% | -23.1% | -22.7% |
| 1 y1 year | +73.4% | -27.2% | -26.3% |
| 5 y5 years | +52.3% | +14.4% | -12.4% |
DNLI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.9% | -6.27 | +30.0% | |
| 3 m | 3-month | -4.03 | -8.9% | -7.16 | +38.7% |
| 6 m | 6-month | -4.03 | -8.9% | -9.09 | +51.7% |
| 1 y | 1-year | -4.03 | -8.9% | -16.71 | +73.7% |
| 3 y | 3-year | -4.03 | -8.9% | -29.56 | +85.2% |
| 5 y | 5-year | 187.57 | -102.3% | -47.42 | +90.7% |
| alltime | all time | 187.57 | -102.3% | -58.31 | +92.5% |
Denali Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -4.39(-23.1%) |
| 2024 | -5.71(-64.3%) |
| 2023 | -15.99(+45.8%) |
| 2022 | -10.97(-39.7%) |
| Date | Value |
|---|---|
| 2021 | -18.19(-113.4%) |
| 2020 | 135.54(-1767.2%) |
| 2019 | -8.13(-83.1%) |
| 2018 | -48.22(+265.0%) |
| 2017 | -13.21 |
FAQ
- What is Denali Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Denali Therapeutics?
- What is DNLI EV/EBITDA year-to-date change?
- What is Denali Therapeutics EV/EBITDA year-on-year change?
What is Denali Therapeutics EV/EBITDA?
The current EV/EBITDA of DNLI is -4.39
What is the all time high EV/EBITDA for Denali Therapeutics?
Denali Therapeutics all-time high EV/EBITDA is 187.57
What is DNLI EV/EBITDA year-to-date change?
Denali Therapeutics EV/EBITDA has changed by +1.32 (+23.12%) since the beginning of the year
What is Denali Therapeutics EV/EBITDA year-on-year change?
Over the past year, DNLI EV/EBITDA has changed by +12.11 (+73.39%)